Axcelis (ACLS) r&d spend was $109M in FY2025 (+3% YoY). The tables below show the complete quarterly and annual r&d spend history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual R&D Spend
Fiscal Year
R&D Spend
YoY
2025
$109M
+3%
2024
$105M
+9%
2023
$97M
+24%
2022
$78M
+20%
2021
$65M
+6%
2020
$62M
+15%
2019
$54M
+4%
2018
$52M
+20%
2017
$43M
+25%
2016
$34M
+6%
2015
$33M
-3%
2014
$34M
-4%
2013
$35M
-14%
2012
$40M
-14%
2011
$47M
+19%
2010
$40M
+21%
2009
$33M
Recent Quarterly R&D Spend
Quarter
R&D Spend
Q2 2026
$29M
Q1 2026
$29M
Q4 2025
$30M
Q3 2025
$25M
Q2 2025
$27M
Q1 2025
$27M
Q4 2024
$28M
Q3 2024
$26M
Q2 2024
$26M
Q1 2024
$26M
Q4 2023
$25M
Q3 2023
$24M
Source: ACLS on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.